Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer Evolution Constrained by the Immune Microenvironment.

Literature DB >> 28841415

Cancer Evolution Constrained by the Immune Microenvironment.

Abstract

Tumor development is a Darwinian evolutionary process, involving the interplay between cancer subclones and the local immune microenvironment. These complex interactions are highlighted in this issue of Cell by the results from Jiménez-Sánchez et al. of a deep analysis of one patient with advanced serous carcinoma of the ovary.

Entities: Disease Species

Mesh：

Year: 2017 PMID： 28841415 DOI： 10.1016/j.cell.2017.08.012

Source DB: PubMed Journal: Cell ISSN： 0092-8674 Impact factor: 41.582

Keyword Cloud
Cited

20 in total

1. The Agpat4/LPA axis in colorectal cancer cells regulates antitumor responses via p38/p65 signaling in macrophages.

Authors: Dapeng Zhang; Rongchen Shi; Wei Xiang; Xia Kang; Bo Tang; Chuan Li; Linfeng Gao; Xuan Zhang; Lili Zhang; Rongyang Dai; Hongming Miao
Journal: Signal Transduct Target Ther Date: 2020-03-27

2. The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy.

Authors: Kostyantyn Krysan; Linh M Tran; Brandon S Grimes; Gregory A Fishbein; Atsuko Seki; Brian K Gardner; Tonya C Walser; Ramin Salehi-Rad; Jane Yanagawa; Jay M Lee; Sherven Sharma; Denise R Aberle; Arum E Spira; David A Elashoff; William D Wallace; Michael C Fishbein; Steven M Dubinett
Journal: Cancer Res Date: 2019-05-29 Impact factor: 12.701

Review 3. Inflammation and Cancer: Triggers, Mechanisms, and Consequences.

Authors: Florian R Greten; Sergei I Grivennikov
Journal: Immunity Date: 2019-07-16 Impact factor: 31.745

4. Identification and Experimental Validation of Immune-Associate lncRNAs for Predicting Prognosis in Cervical Cancer.

Authors: Jing Ye; Xiaojing Chen; Weiguo Lu
Journal: Onco Targets Ther Date: 2021-09-07 Impact factor: 4.147

5. Entinostat induces antitumor immune responses through immune editing of tumor neoantigens.

Authors: Andrew S Truong; Mi Zhou; Bhavani Krishnan; Takanobu Utsumi; Ujjawal Manocha; Kyle G Stewart; Wolfgang Beck; Tracy L Rose; Matthew I Milowsky; Xiaping He; Christof C Smith; Lisa M Bixby; Charles M Perou; Sara E Wobker; Sean T Bailey; Benjamin G Vincent; William Y Kim
Journal: J Clin Invest Date: 2021-08-16 Impact factor: 19.456

6. Predictive value of intratumor metabolic and heterogeneity parameters on [¹⁸F]FDG PET/CT for EGFR mutations in patients with lung adenocarcinoma.

Authors: Ming Ni; Shicun Wang; Xin Liu; Qin Shi; Xingxing Zhu; Yifan Zhang; Qiang Xie; Weifu Lv
Journal: Jpn J Radiol Date: 2022-10-11 Impact factor: 2.701

Cancer Evolution Constrained by the Immune Microenvironment.

1. The Agpat4/LPA axis in colorectal cancer cells regulates antitumor responses via p38/p65 signaling in macrophages.

2. The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy.

Review 3. Inflammation and Cancer: Triggers, Mechanisms, and Consequences.

4. Identification and Experimental Validation of Immune-Associate lncRNAs for Predicting Prognosis in Cervical Cancer.

5. Entinostat induces antitumor immune responses through immune editing of tumor neoantigens.

6. Predictive value of intratumor metabolic and heterogeneity parameters on [¹⁸F]FDG PET/CT for EGFR mutations in patients with lung adenocarcinoma.

Review 7. Defining the Hallmarks of Metastasis.

8. EZH2 inhibition: a promising strategy to prevent cancer immune editing.

9. Evolution and Impact of Subclonal Mutations in Papillary Thyroid Cancer.

10. Clinical relevance of mutant-allele tumor heterogeneity and lung adenocarcinoma.